期刊文献+

支气管内超声引导针吸活检术对肺癌经正电子发射计算机体层摄影检查诊断纵隔阳性淋巴结的评估 被引量:3

Value of endobronchial ultrasound-transbronchial needle aspiration biopsy for diagnosis of PET-CT positive mediastinal lymph nodes
原文传递
导出
摘要 目的评价支气管内超声引导针吸活检术(EBUS—TBNA)对肺癌患者应用正电子发射计算机体层摄影(PET—CT)诊断纵隔阳性淋巴结的评估。方法回顾性分析2008年7月至2010年8月间接受PET—CT和EBUS—TBNA检查的126例肺癌患者的临床相关资料和穿刺活检的结果。结果126例患者成功穿刺185组淋巴结。PET-CT检查结果显示,肺癌并纵隔淋巴结代谢增高,异常浓聚,标准摄取值(SUV)〉2.5。EBUS—TBNA检查可见纵隔多组淋巴结,大小约6~23mm,平均13.6mm。对PET—CT诊断为纵隔阳性的淋巴结再行EBUS—TBNA,EBUS—TBNA诊断的准确性为95.7%,灵敏度为95.7%,特异度为100%。结论EBUS-TBNA作为纵隔淋巴结病理诊断的一种检查方法,其创伤性小,准确性高,对肺癌患者经PET—CT检查为纵隔阳性淋巴结诊断的评估是安全、可行和有效的。 Objective To evaluate the clinical value of endobronchial ultrasound-transbronchial needle aspiration (EBUS-TBNA) biopsy for diagnosis of PET-CT positive mediastinal lymph nodes. Methods One hundred and twenty-six patients with lung cancer undergoing both PET-CT scanning and EBUS-TBNA biopsy in the First Affiliated Hospital of Guanzhou Medical College from July 2008 to August 2010 were included in this study. There were 89 male and 37 female patients with a mean age of 56.3 years (range 34 to 81 years). 18FDG-PET was considered positive in mediastinal nodes if the PET-CT reported hypermetabolic activity consistent with malignant disease ( standardized uptake value 〉 2.5 ). All of the patients were clinically followed up. Results Among the 126 patients, 185 stations of lymph nodes were punctured. The mean diameter of the nodes was 13.6 mm and the range was 6-23 mm. There were no procedural complications. The diagnostic accuracy, sensitivity, and specificity of EBUS-TBNA were 95.7%, 95.7%, and 100%, respectively. Conclusions EBUS-TBNA is a minimally invasive, highly effective and accurate, practical and safe procedure for diagnosis of PET-CT positive mediastinal lymph nodes.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2012年第8期613-615,共3页 Chinese Journal of Oncology
基金 广东省科技厅一般项目基金(030801357)
关键词 肺肿瘤 支气管内超声引导针吸活检术 正电子发射计算机体层摄影 纵隔 淋巴结 Lung neoplasms Endobronchial uhrasound-transbronchial needle aspiration Positron emission tomography-computed tomography Mediastinum Lymph node
  • 相关文献

参考文献14

  • 1Ung YC, Maziak DE, Vanderveen JA, et al. 18 Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer : a systematic review. J Natl Cancer Inst, 2007, 99 : 1753-1767.
  • 2Silvestri GA, Tanoue LT, Margolis ML, et al. The noninvasive staging of non-small cell lung cancer: the guidelines. Chest, 2003, 123 (1Suppl) : 147S-156S.
  • 3何建行,钟南山,杨海虹.美国国家综合癌症网络2008 V2非小细胞肺癌临床实践指南精确解读[J].中华医学杂志,2008,88(40):2814-2816. 被引量:11
  • 4Herth FJ, Eberhardt R. Actual role of endobronchial ultrasound (EBUS). Eur Radiol, 2007, 17:1806-1812.
  • 5Herth FJ, Eberhardt R, Vilmann P, et al. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax, 2006, 61:795-798.
  • 6Yasufuku K, Chiyo M, Sekine Y, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. Chest, 2004, 126:122-128.
  • 7李时悦,陈小波,何颖,汪金林,陈愉,钟南山.气管内超声实时引导经支气管针吸术对肺癌纵隔肺门淋巴结的诊断价值[J].中华医学杂志,2009,89(24):1672-1675. 被引量:38
  • 8Lee HS, Lee GK, Lee HS, et al. Real-time endobronchial ultrasound- guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station? Chest, 2008, 134:368-374.
  • 9李树本,何建行,陈汉章,葛林虎,韦兵,殷伟强,成向阳,刘君,徐鑫.纳米炭在微创肺癌淋巴结清扫术中的应用[J].中华肿瘤杂志,2008,30(3):228-230. 被引量:8
  • 10Detterbeck FC, Jantz MA, Wallace M, et al. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines(2nd edition). Chest, 2007, 132(3 Suppl) :202s-220s.

二级参考文献28

  • 1张镜如 乔健天.生理学[M].北京:人民卫生出版社,1996.85-146.
  • 2Gajra A, Newman N, Gamble GP, et al. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol, 2003, 21:1029-1034.
  • 3Okamoto K, Sawai K, Minato H, et al. Number and anatomical extent of lymph node metastases in gastric cancer: analysis using intra-lymph node injection of activated carbon particles ( CH40 ). Jpn J Clin Oncol, 1999, 29:74-77.
  • 4Naruke T, Suemasu K, Ishlkawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg, 1978, 76:832-839.
  • 5Stella B, Arpicco S, Peracchia MT, et al. Design of folic acidconjugated nanoparticles for drug targeting. J Phann Sci, 2000, 89 : 1452-1464.
  • 6Watanahe A, Koyanagi T, Ohsawa H, et al. Systematic node dissection by VATS is not inferior to that through an open thoracotomy: a comparative clinicopathologic retrospective study. Surgery, 2005, 138:510-517.
  • 7Ludwig MS, Goodman M, Miller DL, et al. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest, 2005, 128:1545-1550.
  • 8Smythe WR. Treatment of stage Ⅰ non-small cell lung carcinoma. Chest, 2003, 123:181S-187S.
  • 9Macbeth FR, Lester JF. Quality of life assessment in the TAX 326 study. Lung Cancer, 2006, 53: 231-239.
  • 10De Pas T, Putzu C, Curigliano G, et al. Aproper schedule of weekly paslitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients. Lung Cancer, 2006, 54: 359 -364.

共引文献52

同被引文献16

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部